Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:KLDO NASDAQ:STIX NASDAQ:STRM NASDAQ:XTKG On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeKLDOKaleido Biosciences$0.00$0.00$0.00▼$0.07$4K-0.0612,338 shs1,222 shsSTIXSemantix$0.00$0.28▼$4.77$23.73M-0.3752,087 shsN/ASTRMStreamline Health Solutions$5.32+0.1%$5.04$1.82▼$9.45$23.17M2.0717,181 shs1,197 shsXTKGX3$2.10+9.9%$1.63$0.53▼$9.14$28.81M1.4864,152 shs61,878 shsThe Best High-Yield Dividend Stocks for 2025Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceKLDOKaleido Biosciences0.00%0.00%0.00%-95.00%0.00%STIXSemantix0.00%0.00%0.00%0.00%-99.56%STRMStreamline Health Solutions0.00%+0.28%+2.31%+83.28%-21.26%XTKGX30.00%+16.41%+24.26%+79.49%-72.58%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationKLDOKaleido BiosciencesN/AN/AN/AN/AN/AN/AN/AN/ASTIXSemantixN/AN/AN/AN/AN/AN/AN/AN/ASTRMStreamline Health SolutionsN/AN/AN/AN/AN/AN/AN/AN/AXTKGX3N/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceKLDOKaleido Biosciences 0.00N/AN/AN/ASTIXSemantix 0.00N/AN/AN/ASTRMStreamline Health Solutions 4.00Strong BuyN/AN/AXTKGX3 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownCompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookKLDOKaleido Biosciences$1.10M0.00N/AN/AN/A∞STIXSemantix$264.23M0.00N/AN/A$1.01 per share0.00STRMStreamline Health Solutions$17.90M1.29N/AN/A$2.87 per share1.85XTKGX3$11.61M2.48N/AN/A$3.64 per share0.58Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateKLDOKaleido BiosciencesN/A-$2.24N/AN/AN/AN/AN/AN/AN/ASTIXSemantix-$63.61M-$0.81N/AN/AN/A-69.49%-45.45%-26.98%N/ASTRMStreamline Health Solutions-$10.16M-$2.28N/A∞N/A-49.32%-68.23%-24.77%9/9/2025 (Estimated)XTKGX3-$76.24MN/A0.00∞N/AN/AN/AN/AN/ALatest KLDO, XTKG, STIX, and STRM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails6/17/2025Q1 2026STRMStreamline Health Solutions-$0.45-$0.40+$0.05-$0.40$4.70 million$4.81 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthKLDOKaleido BiosciencesN/AN/AN/AN/AN/ASTIXSemantixN/AN/AN/AN/AN/ASTRMStreamline Health SolutionsN/AN/AN/AN/AN/AXTKGX3N/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioKLDOKaleido BiosciencesN/AN/AN/ASTIXSemantixN/A1.611.61STRMStreamline Health SolutionsN/A0.270.27XTKGX3N/A0.740.74Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipKLDOKaleido Biosciences81.56%STIXSemantix40.12%STRMStreamline Health Solutions31.74%XTKGX31.85%Insider OwnershipCompanyInsider OwnershipKLDOKaleido Biosciences9.00%STIXSemantix35.50%STRMStreamline Health Solutions30.59%XTKGX323.90%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableKLDOKaleido Biosciences8042.62 million38.79 millionNot OptionableSTIXSemantix479.10 million51.02 millionNot OptionableSTRMStreamline Health Solutions1304.36 million3.02 millionNot OptionableXTKGX320013.72 million10.44 millionN/AKLDO, XTKG, STIX, and STRM HeadlinesRecent News About These CompaniesX3 Holdings Co LtdMay 29, 2025 | uk.investing.comX3 Holdings regains compliance with Nasdaq minimum bid price deficiencyApril 17, 2025 | markets.businessinsider.comX3 Holdings Has Regained Compliance with Nasdaq's Minimum Bid Price DeficiencyApril 16, 2025 | prnewswire.comX3 Holdings Announces Share ConsolidationNovember 19, 2024 | prnewswire.comX3 Holdings Announces Annual General Meeting ResultsNovember 8, 2024 | prnewswire.comX3 Holdings Receives Extension to Regain Compliance with the Nasdaq's Minimum Bid Price RequirementOctober 11, 2024 | prnewswire.comX3 Holdings (NASDAQ:XTKG) Stock Quotes, Forecast and News SummaryOctober 7, 2024 | benzinga.comX3 Holdings Enters High-Growth Digital Game Market with Strategic AcquisitionSeptember 26, 2024 | prnewswire.comX3 Holdings Co Ltd XTKGAugust 7, 2024 | morningstar.comMX3 Holdings Co Ltd (XTKG)July 21, 2024 | investing.comX3 Holdings Co Full Year 2023 Earnings: US$3.57 loss per share (vs US$44.65 loss in FY 2022)May 2, 2024 | finance.yahoo.comX3 Holdings Co. Ltd.April 22, 2024 | wsj.comX3 Holdings Co., Ltd.: X3 Holdings Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyApril 11, 2024 | finanznachrichten.deX3 Holdings Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price DeficiencyApril 11, 2024 | prnewswire.comCannabis Stocks Alert: Recreational Marijuana Just Became Legal in GermanyApril 1, 2024 | investorplace.comWhy Is X3 Holdings (XTKG) Stock Down 25% Today?April 1, 2024 | msn.comX3 Holdings Strikes Major Partnership Deal, Poised to Transform Semiconductor Supply ChainsApril 1, 2024 | finance.yahoo.comWhy Is X3 Holdings (XTKG) Stock Down 25% Today?April 1, 2024 | investorplace.comX3 Holdings Co., Ltd. Ordinary Shares (XTKG)March 31, 2024 | nasdaq.comX3 Holdings Declares Common Stock Dividend to Boost Shareholder Value and LiquidityMarch 6, 2024 | businesswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeKLDO, XTKG, STIX, and STRM Company DescriptionsKaleido Biosciences NASDAQ:KLDO$0.0001 0.00 (0.00%) As of 08/1/2025 09:34 AM EasternKaleido Biosciences, Inc., a clinical-stage healthcare company, develops microbiome metabolic therapies. The company develops KB195 for the treatment of patients with urea cycle disorder; KB295 to treat ulcerative colitis; KB174 for the treatment of hepatic encephalopathy; and KB109 to treat COVID-19 disease. It also develops programs for the treatment of multi drug resistant infection, chronic kidney disease, atherosclerotic cardiovascular disease, cardio-metabolic syndrome, immuno-oncology, and inflammatory bowel diseases. The company has collaboration agreements with Institute Gustave Roussy, Washington University, and Janssen. Kaleido Biosciences, Inc. was incorporated in 2015 and is headquartered in Lexington, Massachusetts.Semantix NASDAQ:STIXSemantix, Inc., together with its subsidiaries, provides end-to-end proprietary Software as a Service (SaaS) data platform in Latin America and the United States. The company offers SDP, a multi-cloud SaaS data platform that provides data integration, data operations, machine learning operations, data governance, data sharing, and data visualization for financial institutions; healthcare plans operators, health insurance brokers, hospitals, clinics, and imaging and diagnostics facilities; and retailers. It also sells third-party software licenses to the finance, retail, telecommunications, healthcare, industrials, and other sectors. In addition, the company offers artificial intelligence and data analytics services, including consulting, cloud monitoring, data integration, data science, and data engineering. The company was founded in 2010 and is based in São Paulo, Brazil.Streamline Health Solutions NASDAQ:STRM$5.32 +0.01 (+0.09%) As of 08/1/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management. It also provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.X3 NASDAQ:XTKG$2.10 +0.19 (+9.95%) Closing price 08/1/2025 03:58 PM EasternExtended Trading$2.08 -0.02 (-0.71%) As of 08/1/2025 06:19 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.X3 Holdings Co Ltd. provides technology solutions and services worldwide. The company offers Global Trade Platform, a digital platform for trading partners, service providers, and government authorities. It also engages in bitcoin cryptomining operations, renewable energy projects, and agriculture technologies and trading. The company was formerly known as Powerbridge Technologies Co., Ltd. and changed its name to X3 Holdings Co Ltd. in January 2024. X3 Holdings Co Ltd. was founded in 1997 and is headquartered in Singapore. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 07/28 - 08/01 Alphabet Gains Momentum as Sentiment on Wall Street Improves Amazon's Earnings: What Comes Next and How to Play It Apple Stock: Big Earnings, Small Move—Time to Buy? Tesla Teams With Samsung—Will Other Chipmakers Follow? Will Hims & Hers Fall Along With Novo Nordisk? UPS's 7.5% Dividend: A Blue-Chip Stock on a Once-in-a-Decade Sale Is PG&E an AI Power Play? Why Options Traders Are Betting Big Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
